GNP[removed]MOSL-RU-8PG.p65

First Page		Document Content
Date: 2012-02-02 00:40:41 Financial ratios Fundamental analysis Valuation Earnings before interest taxes depreciation and amortization Private equity EV/EBITDA Income P/E ratio Glenmark Pharmaceuticals Finance Investment Financial economics		GNP[removed]MOSL-RU-8PG.p65 Add to Reading List Source URL: smartinvestor.business-standard.com Download Document from Source Website File Size: 155,21 KB Share Document on Facebook

	HIGHLIGHTS • Revenues in 3Q13 were 5,336 TUSD compared to last year’s launch quarter of The Secret World 10,963 TUSD for 3Q12. • Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) for 3Q13 were DocID: 1umA3 - View Document
	The term EBITDA is used by the Company in presentations, quarterly conference calls and other instances as appropriate. EBITDA is defined as net income before interest, income taxes, depreciation and amortization. The Co DocID: 1udZc - View Document
	The term “EBITDA” is used by the Company in presentations, quarterly conference calls and other instances as appropriate. EBITDA is defined as net income before interest, income taxes, depreciation and amortization. DocID: 1tP2e - View Document
	Results for the Quarter Ended June 30, 2016 K-IFRS, Non-audited July 28th, 2016 DocID: 1ru8X - View Document
	Second Quarter 2004 Results FOR IMMEDIATE RELEASE Highlights ¾ Record second-quarter Consolidated and Television Broadcasting segment net sales, operating income before depreciation and amortization and margins DocID: 1rshF - View Document